File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10-29 years after initial remission

TitleClinicopathological features and outcome of late relapses of natural killer cell lymphomas 10-29 years after initial remission
Authors
Issue Date2010
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/35105
Citation
American Journal Of Hematology, 2010, v. 85 n. 5, p. 362-363 How to Cite?
AbstractNatural killer (NK)-cell lymphomas are aggressive and relapses occur early. Late relapses are exceptional. Ten relapses 17.5 (11-29) years after first complete remission (CR1) were analyzed. Initial diseases were stage-I (nasal, n = 8; tonsil, n = 1; ileum, n = 1), treated with radiotherapy (n = 6), combined radiotherapy/chemotherapy (n = 3), and chemotherapy (n = 1). Relapse occurred at the same (nasal, n = 6; tonsil, n = 1), adjacent (initial: nasal, relapse: palate; n = 1) or distant (n = 2) sites. Five patients died soon afterwards. Four patients remitted with chemotherapy, two remaining in CR2 (3, 14 years). This series documented the rare late relapses in NK-cell lymphomas, which may still respond to salvage therapy. © 2010 Wiley-Liss, Inc.
Persistent Identifierhttp://hdl.handle.net/10722/163307
ISSN
2015 Impact Factor: 5.0
2015 SCImago Journal Rankings: 1.761
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorAu, WYen_US
dc.contributor.authorKim, SJen_US
dc.contributor.authorYiu, HHYen_US
dc.contributor.authorNgan, RKCen_US
dc.contributor.authorLoong, Fen_US
dc.contributor.authorKim, WSen_US
dc.contributor.authorKwong, YLen_US
dc.date.accessioned2012-09-05T05:29:53Z-
dc.date.available2012-09-05T05:29:53Z-
dc.date.issued2010en_US
dc.identifier.citationAmerican Journal Of Hematology, 2010, v. 85 n. 5, p. 362-363en_US
dc.identifier.issn0361-8609en_US
dc.identifier.urihttp://hdl.handle.net/10722/163307-
dc.description.abstractNatural killer (NK)-cell lymphomas are aggressive and relapses occur early. Late relapses are exceptional. Ten relapses 17.5 (11-29) years after first complete remission (CR1) were analyzed. Initial diseases were stage-I (nasal, n = 8; tonsil, n = 1; ileum, n = 1), treated with radiotherapy (n = 6), combined radiotherapy/chemotherapy (n = 3), and chemotherapy (n = 1). Relapse occurred at the same (nasal, n = 6; tonsil, n = 1), adjacent (initial: nasal, relapse: palate; n = 1) or distant (n = 2) sites. Five patients died soon afterwards. Four patients remitted with chemotherapy, two remaining in CR2 (3, 14 years). This series documented the rare late relapses in NK-cell lymphomas, which may still respond to salvage therapy. © 2010 Wiley-Liss, Inc.en_US
dc.languageengen_US
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/35105en_US
dc.relation.ispartofAmerican Journal of Hematologyen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols - Therapeutic Useen_US
dc.subject.meshCohort Studiesen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshLymphoma - Drug Therapy - Physiopathologyen_US
dc.subject.meshMaleen_US
dc.subject.meshNatural Killer T-Cells - Pathologyen_US
dc.subject.meshNeoplasm Recurrence, Local - Drug Therapyen_US
dc.subject.meshNose Neoplasms - Drug Therapy - Physiopathologyen_US
dc.subject.meshRetrospective Studiesen_US
dc.subject.meshSalvage Therapyen_US
dc.subject.meshSurvivorsen_US
dc.subject.meshYoung Adulten_US
dc.titleClinicopathological features and outcome of late relapses of natural killer cell lymphomas 10-29 years after initial remissionen_US
dc.typeArticleen_US
dc.identifier.emailKwong, YL:ylkwong@hku.hken_US
dc.identifier.authorityKwong, YL=rp00358en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1002/ajh.21663en_US
dc.identifier.pmid20229594-
dc.identifier.scopuseid_2-s2.0-77951558521en_US
dc.identifier.hkuros180710-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-77951558521&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume85en_US
dc.identifier.issue5en_US
dc.identifier.spage362en_US
dc.identifier.epage363en_US
dc.identifier.isiWOS:000277325800013-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridAu, WY=7202383089en_US
dc.identifier.scopusauthoridKim, SJ=8702924000en_US
dc.identifier.scopusauthoridYiu, HHY=6603694447en_US
dc.identifier.scopusauthoridNgan, RKC=6701397734en_US
dc.identifier.scopusauthoridLoong, F=6602794154en_US
dc.identifier.scopusauthoridKim, WS=34975082200en_US
dc.identifier.scopusauthoridKwong, YL=7102818954en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats